Company profile for MedinCell

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. c...
MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. compliance with medical prescriptions, and to a significant reduction in the quantity of medication required as part of a one-off or chronic treatment.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
3 rue des Frères Lumière, Jacou, Occitanie 34830, FR
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-12-09/medincell-publishes-its-consolidated-half-year-financial-results

PHARMIWEB
09 Dec 2025

https://www.pharmiweb.com/press-release/2025-12-01/medincell-videoconference-and-publication-of-half-year-financial-results-tuesday-december-9-2025

PHARMIWEB
01 Dec 2025

https://www.businesswire.com/news/home/20251110591981/en/Medincell-Appoints-Dr-Grace-Kim-Chief-Strategy-Officer-U.S.-Finance-to-Advance-into-Next-Stage-of-US-Capital-Growth

BUSINESSWIRE
11 Nov 2025

https://www.businesswire.com/news/home/20251110138231/en/Medincell-to-Join-MSCI-World-Small-Cap-Index-a-Leading-Global-Benchmark

BUSINESS WIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/10/10/3165077/0/en/FDA-Approves-Expanded-Indication-for-UZEDY-risperidone-Extended-Release-Injectable-Suspension-as-a-Treatment-for-Adults-Living-with-Bipolar-I-Disorder.html

GLOBENEWSWIRE
10 Oct 2025

https://www.pharmiweb.com/press-release/2025-09-23/teva-and-medincell-s-risperidone-lai-approved-in-canada-as-longavo

PHARMAWEB
23 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty